This Article Full Text (PDF) All Versions of this Article: 1074248409338929v1 14/3/222    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Aidonidis, I. Articles by Molyvdas, P.-A. PubMed PubMed Citation Articles by Aidonidis, I. Articles by Molyvdas, P.-A. Social Bookmarking                         What's this?

Dose-Related Shortening of Ventricular Tachycardia Cycle Length After Administration of the KATP Channel Opener Bimakalim in a 4-Day-Old Chronic Infarct Anesthetized Pig Model

Department of Physiology Medical School of Athens, University of Athens, Athens, Greece, iahd93{at}otenet.gr, iaido{at}med.uth.gr

Aphrodite Poyatzi, MD

Department of Physiology, Medical School of Athens, University of Athens, Athens, Greece

Georgia Stamatiou, MD

University Hospital of Larissa Medical School of Larrissa, University of Thessaly, Greece

Maria Lymberi, MD

Department of Physiology, Medical School of Athens, University of Athens, Athens, Greece

Nikolaos Stamatoyannis, MD

Department of Intensive Station Medical School of Athens, University of Athens, Athens, Greece

Paschalis-Adam Molyvdas, MD

Department of Physiology Medical School of Athens, University of Athens, Athens, Greece

Potassium channel openers are known to act on potassium ATP-dependent channels in cardiac tissue. Such agents may exacerbate acceleration of acute ischemia-induced ventricular repolarization and aggravate arrhythmias. To test whether activation of K _ATP channels during the healing period of myocardial infarction (MI) can still influence the electrophysiologic properties and the type of inducible arrhythmias, we investigated the effects of bimakalim (BIM) on sustained ventricular tachycardia (VT) 4 days after ligation of the left anterior descending (LAD) coronary artery in pigs. Programmed stimulation was performed to elicit VT prior to and after intravenous (IV) BIM. Combination monophasic action potential (MAP)/PACING catheters were used to enable simultaneous ventricular MAP recording and pacing. Ventricular effective refractory period (ERP) and MAP duration determined at 50% and 90% repolarization were measured prior to and after BIM. After completion of baseline measurements, BIM was consecutively given at 0.5, 1, and 3 mg/kg bolus followed by 0.025, 0.05, and 0.1 mg/kg per minute maintenance infusion, respectively. From a total of 23 pigs subjected to LAD ligation, 4 animals succumbed to infarction and the remaining 19 animals were studied by programmed stimulation. Only animals that exhibited reproducible and hemodynamically stable monomorphic VTs during control stimulation were selected for evaluation (n = 14). After the first, second, and third dose of BIM, the mean VT rate was increased by 6%, 14% (P <. 01), and 47% (P < .001) compared to control values, respectively. Ventricular ERP and repolarization were significantly shortened only by the second and third dose of BIM. Of 14 pigs receiving the highest BIM dosage, 3 revealed polymorphic VTs degenerating into ventricular fibrillation (VF). Our data suggest that high BIM doses may lead to faster and more aggressive pacing-induced reentrant VTs after subacute MI. This is consistent with the drug-induced acceleration of ventricular repolarization with shortening of MAP duration and refractoriness.

Key Words: anesthetized pigs • subacute myocardial infarction • monophasic action potentials • programmed stimulation • sustained ventricular tachycardia • bimakalim

This version was published on September 1, 2009

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 14, No. 3, 222-230 (2009)
DOI: 10.1177/1074248409338929


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?